The Centers for Medicare & Medicaid Services has revised the way Medicare administrative contractors make local coverage determinations for medical technologies, as required by the 21st Century Cures Act to promote transparency. Among other changes, the updated process expands who can participate on the contractor advisory committees that inform LCDs, opens CAC meetings to the public and requires a standardized summary of the clinical evidence supporting an LCD decision. CMS said the changes, published as an update to the Medicare Program Integrity Manual, will clarify and simplify the LCD process so that companies can get therapies and devices to patients more efficiently.

Related News Articles

Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027. CMS…